These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 37545515)

  • 21. Identification of a LolC homologue in Burkholderia pseudomallei, a novel protective antigen for melioidosis.
    Harland DN; Chu K; Haque A; Nelson M; Walker NJ; Sarkar-Tyson M; Atkins TP; Moore B; Brown KA; Bancroft G; Titball RW; Atkins HS
    Infect Immun; 2007 Aug; 75(8):4173-80. PubMed ID: 17517877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of an OmpW homologue in Burkholderia pseudomallei, a protective vaccine antigen against melioidosis.
    Casey WT; Spink N; Cia F; Collins C; Romano M; Berisio R; Bancroft GJ; McClean S
    Vaccine; 2016 May; 34(23):2616-21. PubMed ID: 27091689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protection against experimental melioidosis following immunisation with a lipopolysaccharide-protein conjugate.
    Scott AE; Ngugi SA; Laws TR; Corser D; Lonsdale CL; D'Elia RV; Titball RW; Williamson ED; Atkins TP; Prior JL
    J Immunol Res; 2014; 2014():392170. PubMed ID: 24892035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mucosal immunization with liposome-nucleic acid adjuvants generates effective humoral and cellular immunity.
    Henderson A; Propst K; Kedl R; Dow S
    Vaccine; 2011 Jul; 29(32):5304-12. PubMed ID: 21600950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of capsular polysaccharide-based glycoconjugates for immunization against melioidosis and glanders.
    Burtnick MN; Heiss C; Roberts RA; Schweizer HP; Azadi P; Brett PJ
    Front Cell Infect Microbiol; 2012; 2():108. PubMed ID: 22912938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Burkholderia pseudomallei capsular polysaccharide conjugates provide protection against acute melioidosis.
    Scott AE; Burtnick MN; Stokes MG; Whelan AO; Williamson ED; Atkins TP; Prior JL; Brett PJ
    Infect Immun; 2014 Aug; 82(8):3206-13. PubMed ID: 24866807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A model of immunity to Burkholderia pseudomallei: unique responses following immunization and acute lethal infection.
    Ulett GC; Labrooy JT; Currie BJ; Barnes JL; Ketheesan N
    Microbes Infect; 2005; 7(11-12):1263-75. PubMed ID: 16027024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intranasal immunization with an epitope-based vaccine results in earlier protection, but not better protective efficacy, against Helicobacter pylori compared to subcutaneous immunization.
    Li H; Zhang J; He Y; Li B; Chen L; Huang W; Zou Q; Wu C
    Immunol Res; 2015 Jul; 62(3):368-76. PubMed ID: 26044541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunogenic recombinant Burkholderia pseudomallei MprA serine protease elicits protective immunity in mice.
    Chin CY; Tan SC; Nathan S
    Front Cell Infect Microbiol; 2012; 2():85. PubMed ID: 22919676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel multi-component vaccine approaches for Burkholderia pseudomallei.
    Morici L; Torres AG; Titball RW
    Clin Exp Immunol; 2019 May; 196(2):178-188. PubMed ID: 30963550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Caprine humoral response to Burkholderia pseudomallei antigens during acute melioidosis from aerosol exposure.
    Yi J; Simpanya MF; Settles EW; Shannon AB; Hernandez K; Pristo L; Keener ME; Hornstra H; Busch JD; Soffler C; Brett PJ; Currie BJ; Bowen RA; Tuanyok A; Keim P
    PLoS Negl Trop Dis; 2019 Feb; 13(2):e0006851. PubMed ID: 30811382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunization with the recombinant Burkholderia pseudomallei outer membrane protein Omp85 induces protective immunity in mice.
    Su YC; Wan KL; Mohamed R; Nathan S
    Vaccine; 2010 Jul; 28(31):5005-11. PubMed ID: 20546831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heterologously type IV pilus expressed protein of Burkholderia pseudomallei is immunogenic but fails to induce protective immunity in mice.
    Sangdee K; Waropastrakul S; Wongratanachewin S; Homchampa P
    Southeast Asian J Trop Med Public Health; 2011 Sep; 42(5):1190-6. PubMed ID: 22299445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intranasal immunization with a non-adjuvanted adhesive protein descended from Pasteurella pneumotropica and its preventive efficacy against opportunistic infection in mice.
    Sasaki H; Ishikawa H; Kojima K; Itoh M; Matsumoto T; Itoh T; Hosomi O; Kawamoto E
    Vaccine; 2013 Nov; 31(48):5729-35. PubMed ID: 24091313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of the nature of adjuvant and site of parenteral immunization on the serum and mucosal immune responses induced by a nasal boost with a vaccine alone.
    Guy B; Fourage S; Hessler C; Sanchez V; Millet MJ
    Clin Diagn Lab Immunol; 1998 Sep; 5(5):732-6. PubMed ID: 9729544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intranasal vaccination induced cross-protective secretory IgA antibodies against SARS-CoV-2 variants with reducing the potential risk of lung eosinophilic immunopathology.
    Hemmi T; Ainai A; Hashiguchi T; Tobiume M; Kanno T; Iwata-Yoshikawa N; Iida S; Sato Y; Miyamoto S; Ueno A; Sano K; Saito S; Shiwa-Sudo N; Nagata N; Tamura K; Suzuki R; Hasegawa H; Suzuki T
    Vaccine; 2022 Sep; 40(41):5892-5903. PubMed ID: 36064667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of immune response to the 17 kDa OMPA Burkholderia cenocepacia polypeptide and protection against pulmonary infection in mice after nasal vaccination with an OMP nanoemulsion-based vaccine.
    Makidon PE; Knowlton J; Groom JV; Blanco LP; LiPuma JJ; Bielinska AU; Baker JR
    Med Microbiol Immunol; 2010 May; 199(2):81-92. PubMed ID: 19967396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic and mucosal immune responses in mice after mucosal immunization with group B streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate vaccine.
    Shen X; Lagergård T; Yang Y; Lindblad M; Fredriksson M; Holmgren J
    Infect Immun; 2000 Oct; 68(10):5749-55. PubMed ID: 10992481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of different adjuvants in the context of intramuscular and intranasal routes on humoral and cellular immune responses induced by detergent-split A/H3N2 influenza vaccines in mice.
    Baz M; Samant M; Zekki H; Tribout-Jover P; Plante M; Lanteigne AM; Hamelin ME; Mallett C; Papadopoulou B; Boivin G
    Clin Vaccine Immunol; 2012 Feb; 19(2):209-18. PubMed ID: 22190392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative virulence of three different strains of Burkholderia pseudomallei in an aerosol non-human primate model.
    Trevino SR; Dankmeyer JL; Fetterer DP; Klimko CP; Raymond JLW; Moreau AM; Soffler C; Waag DM; Worsham PL; Amemiya K; Ruiz SI; Cote CK; Krakauer T
    PLoS Negl Trop Dis; 2021 Feb; 15(2):e0009125. PubMed ID: 33571211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.